Insider · CIK 0001183247
Gilbert F Amelio
Files at GALT (GALECTIN THERAPEUTICS INC). First filing -, latest -.
Gilbert F Amelio files SEC Form 4 as director at GALT (GALECTIN THERAPEUTICS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Gilbert F Amelio has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 16, 2026 | GALT GALECTIN THERAPEUTICS INC | AGrant or award Stock option (right to buy)derivative | +60,000 | $0.00 | $0 | 60,000 | Jan 21, 2026 |
Questions about Gilbert F Amelio
Answered from the filings on this page, as of the latest one.
Is Gilbert F Amelio buying or selling?
Gilbert F Amelio has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Gilbert F Amelio's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gilbert F Amelio has 0.
Where does Gilbert F Amelio file Form 4?
Gilbert F Amelio has filed Form 4 at GALT (GALECTIN THERAPEUTICS INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.